Exane Derivatives’s Cytokinetics CYTK Stock Holding History

Exane Derivatives’s Portfolio CYTK Stock Details CYTK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.08K	Hold
2022 Q1	$1.95K	Hold
2021 Q4	$2.42K	Hold
2021 Q3	$1.89K	Sell
2021 Q2	$30.9K	Hold
2021 Q1	$38.2K	Hold
2020 Q4	$34.1K	Buy